<< Вернуться к списку статей журнала

Том 5 №3 2003 год - Нефрология и диализ

Вирусные инфекции и трансплантация почки (Обзор литературы, часть II)

Прокопенко Е.И. Будникова Н.Е.

Аннотация: В настоящее время известно несколько вирусов гепатита (A, B, C, D, E, G и др.), и число открытых вирусов продолжает расти. Однако в клинической трансплантологии наибольшее значение имеют 2 вируса: вирус гепатита B (HBV) и вирус гепатита C (HCV). В нашей стране распространенность вирусных гепатитов среди пациентов диализных центров и реципиентов почечного трансплантата достаточно высока [2, 3].

Для цитирования: Прокопенко Е.И., Будникова Н.Е. Вирусные инфекции и трансплантация почки (Обзор литературы, часть II). Нефрология и диализ. 2003. 5(3):200-206. doi:

Весь текст

Ключевые слова: вирусы, трансплантация почки, иммуносупрессия

Список литературы:

1. Ватазин А.В., Молочков В.А., Казанцева И.А. и др. Саркома Капоши у больных после трансплантации почки (опыт одного центра). Нефрология и диализ 2001; 1 (2): 86-89.
2. Зубкин М.Л., Селькова Е.П., Стаханова В.М. и др. Гепатит B в центрах гемодиализа Москвы: клинико-эпидемиологическая характеристика. Нефрология и диализ 2001; 3 (4): 442-447.
3. Иванова И.П. Трансплантация почки и гепатиты: особенности диагностики, лечения и профилактики у больных хронической почечной недостаточностью: Автореф. дисс. … канд. мед. наук. 1998; 32.
4. Майер К.-П. Гепатит и последствия гепатита. М.: Гэотар Медицина 1999: 423.
5. Суханов А.В. Полиомавирусная нефропатия трансплантата. Нефрология и диализ 2001; 3 (4): 411-413.
6. Шмарина Н.В., Тарабарко Н.В., Ржевская О.Н. и др. Оценка влияния рекомбинантного интерлейкина-1-бета у больных с терминальной стадией ХПН в лечении вирусных гепатитов B и C до трансплантации почки на течение раннего послеоперационного периода. Вестник трансплантологии и искусственных органов. 2003; 1: 24-27.
7. Ahsan N., Holman M.J., Gocke C.D. et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 1997; 11 (4): 265-270.
8. Ali M., Light G., Barhyte D. et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998; 66: 1694-1697.
9. Baid S., Pascual M., Williams W.W. Jr. et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10 (1): 146-153.
10. Batty D.S. Jr., Swanson S.J., Kirk A.D. et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001 Jul; 1 (2): 179-184.
11. Berthoux P., Dejean C., Cecillon S. et al. High prevalence of hepatitis G virus (HGV) infection in renal transplantation. Nephrol Dial Transplant 1998; 13 (11): 2909-2013.
12. Berthoux P., Laurent B., Cecillon S., Berthoux F. Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient. Am J Nephrol 1999; 19 (4): 513-518.
13. Bertoux F.C., Broyet C., Alamartine E. et al. HBs antigen positive organ donors and anti-HCV positive organ donors in renal transplantation. In: Touraine J.L. et al., eds. Transplantation and Clinical Immunology XXIII. Elsevier Science Publishers BV: 1991.
14. Besisik F., Sever M.S., Dincer D. et al. Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity? Clin Transplant 2000; 14 (6): 529-532.
15. Breitenfeldt M.K., Rasenack J., Berthold H. et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16 (2): 130-136.
16. Campistol J.M., Esforzado N., Andres A. et al. Problematica y resultados del transplante renal con donnates HBsAg o VHC positivos. Nefrologia 1998; 18: 78-81.
17. Campistol J.M., Esforzado N., Andres A. et al. Resultados del transplante renal utilizando rinones de donantes hepatitis C positivos y hepatitis B positiva. Nefrologia 1998; 18: 60-64.
18. Choi S.H., Chang S.P., Won J.C. et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 2002; 34 (1): 71-75.
19. Cruzado J.M., Carrera M., Torras J., Grinyo J.M. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1 (2): 171-178.
20. Dalekos G.N., Zervou E., Elisaf M. et al. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 1998; 38 (6): 589-595.
21. De Filippi F., Lampertico P., Soffredini R. et al. High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients. Dig Liver Dis 2001; 33 (6): 477-479.
22. Delladetsima J.K., Makris F., Psichogiou M. et al. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver 2001; 2; 1 (2): 81-88.
23. Diamantis I., Vafiadis I., Voskaridou E. et al. Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy. Eur J Gastroenterol Hepatol 1998; 10 (1): 75-79.
24. Fishman J.A., Rubin R.H. Medical progress: Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.
25. Fontaine H., Thiers V., Chretien Y. et al. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation 2000; 69 (10): 2090-2094.
26. Fornarion S., Pol S., Legendre C. et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297-299.
27. Gentil M.A., Luna E., Rodriguez-Algarra G. et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17 (5): 887-891.
28. Goffin E., Pirson Y., van Ypersele de Strihou C. Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates. Nephrol Dial Transplant 1995; 10: 88-92.
29. Hanafusa T., Ichikawa Y., Kishikawa H. et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-476.
30. Hanrotel C., Toupance O., Lavaud S. et al. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron 2001; 88 (2): 120-126.
31. Huraib S., Iqbal A., Tanimu D., Abdullah A. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol 2001; 21 (6): 435-440.
32. Ichikawa Y., Kyo M., Hanafusa T. et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 1998; 65 (1): 134-138.
33. Isaacson A.H., Bhardwaj B., Qian K. et al. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat 1999; 6 (2): 151-160.
34. Izopet J., Rostaing L., Sandres K. et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000; 181 (3): 852-858.
35. Jeong H.J., Choi K.H., Chon C.Y. et al. Membranoproliferative glomerulonephritis associated with HCV infection in native kidneys and renal allograft. J Korean Med Sci 1998; 13 (6): 670-675.
36. Jung Y.O., Lee Y.S., Yang W.S. et al. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 1998; 66 (6): 733-737.
37. Kasiske B., Ramos E.L., Gaston R.S. et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1-34.
38. Kletzmayr J., Watschinger B., Muller C. et al. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation 2000; 70 (9): 1404-1407.
39. Knoll G.A., Tankersley M.R., Lee J.Y. et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kid Dis 1997; 29: 608-614.
40. Lamproye A., Delwaide J., Vaira D. et al. Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastroenterol Belg 1999; 62 (1): 13-15.
41. Lee H.K., Yoon G.S., Min K.S. et al. Fibrosing cholestatic hepatitis: a report of three cases. J Korean Med Sci 2000; 15 (1): 111-114.
42. Lee P.C., Hung C.J., Lin Y.J. et al. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 2002; 73 (10): 1635-1639.
43. Lee W.C., Wu M.J., Cheng C.H. et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001; 38 (5): 1074-1081.
44. Lui S.L., Luk W.K., Cheung C.Y. et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71 (1): 59-64.
45. Martin P., Carter D., Fabrizi F. et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69 (7): 1479-1484.
46. Mathurin P., Mouquet C., Poynard T. et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29 (1): 257-263.
47. Molmenti E.P., Jain A.B., Shapiro R. et al. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation 2001; 71 (2): 267-271.
48. Morales J., Campistol J., Castellano G. et al. Transplantations of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236-240.
49. Morales J.M., Campistol J.M., Andres A., Rodicio J.L. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 1998; 7: 177-183.
50. Morales J.M., Pascual-Capdevila J., Campistol J.M. et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63 (11): 1634-1639.
51. Moudgil A., Shidban H., Nast C.C. et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997; 64 (12): 1847-1850.
52. Munos de Bastillo E., Ibarrola C., Andres A. et al. Hepatitis-B-related fibrosing cholestatic hepatitis after renal transplantation with acute renal graft failure following interferon-alfa therapy. Nephrol Dial Transplant 1998; 13: 1574-1576.
53. Munoz de Bustillo E., Ibarrola C., Colina F. et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant patients. J Am Soc Neplirol 1998; 9: 1109-1113.
54. Murer L., Zacchello G., Bianchi D. et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11 (6): 1132-1137.
55. Ok E., Unsal A., Celik A. et al. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. Nephrol Dial Transplant 1998; 13 (12): 3103-3107.
56. Pamidi S., Friedman K., Kampalath B. et al. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000; 69 (12): 2666-2269.
57. Park S.K., Yang W.S., Lee Y.S. et al. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine. Nephrol Dial Transplant 2001; 16 (11): 2222-2228.
58. Pereira B.J., Wright T.L., Schmid C.H., Levey A.S. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-487.
59. Peters M.G., Singer G., Howard T. et al. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 1999; 68 (12): 1912-1914.
60. Pol S., Debure A., Degott C. et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878-880.
61. Pol S., Romeo R., Zins B. et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.
62. Post A.B., Hricik D.E., Sterling R.K. et al. Resolution of hepatitis B viremia in a renal transplant recipient treated with alpha-2b interferon. Nephron 1998; 79 (4): 469-471.
63. Preikschat P., Gunther S., Reinhold S. et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35 (2): 466-477.
64. Puchhammer-Stockl E., Mandl C.W., Kletzmayr J. et al. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis 2000; 181 (6): 2063-2066.
65. Rao K.V., Anderson W.R., Kasiske B.L., Dahl D.C. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241-250.
66. Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765-1769.
67. Rostaing L., Izopet J., Arnaud C. et al. Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation 1999; 67 (4): 556-560.
68. Rostaing L., Izopet J., Baron E. et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426-1431.
69. Rostaing L., Izopet J., Cisterne J.M. et al. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. Transplantation 1998; 65 (7): 930-936.
70. Rostaing L., Izopet J., Sandres K. et al. Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation 2000; 69 (5): 991-994.
71. Rostaing L., Modesto A., Baron E. et al. Acute renal failure in kidney transplant patients treated with interferon alfa 2b for chronic hepatitis C. Nephron 1996; 74: 512-516.
72. Santos F.R., Haiashi A.R., Araujo M.R. et al. Lamivudine therapy for hepatitis B in renal transplantation. Braz J Med Biol Res 2002; 35 (2): 199-203.
73. Stark K., Meyer C.G., Tacke M. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors. Transplantation 1997; 64 (4): 608-612.
74. Tang S., Ho S.K., Moniri K. et al. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant. Transplantation 2002; 73 (1): 148-151.
75. Van Duijnhoven E.M., Christiaans M.H., Boots J.M. et al. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus. Am J Kidney Dis 2002; 40 (1): 195-201.
76. Vosnides G.G. Hepatitis C in renal transplantation. Kidney Int 1997; 52: 843-861.
77. Wong T.Y., Chan P.K., Leung C.B. et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34 (6): 1132-1136.
78. Yokosuka O., Ikeuchi T., Kanda T. et al. The prevalence of TT virus infection in renal transplant recipients in Brazil. Transplantation 2000; 70 (8): 1194-1197.
79. Zylberberg H., Carnot F., Mamzer M.F. et al. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-160.
80. Zylberberg H., Nalpas B., Carnot F. et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002; 17 (1): 129-133.

Другие статьи по теме

• Легочные инфекции у пациентов с почечным трансплантатом
• Вирусные инфекции и трансплантация почки (Обзор литературы, часть I)
• Рациональное использование рапамицина (сиролимуса) в современной многокомпонентной иммуносупрессии при трансплантации почки
• Пиелонефрит нефункционирующего почечного трансплантата, потребовавший выполнения трансплантатэктомии через 23 года после пересадки почки